Table 1.
Baseline characteristics of the study cohort
| Parameters | Donor features (N = 209) | Range (min.–max.) |
|---|---|---|
| Male/female (n) | 122/87 | — |
| Age (years) | 57 (19) | 17–83 |
| Height (m) | 1.7 (0.2) | 1.45–2.0 |
| Weight (Kg) | 80 (20) | 47–160 |
| BMI (Kg/m2) | 27.04 (6) | 16–69 |
| SBP (mm Hg) | 120 (32) | 40–260 |
| DBP (mm Hg) | 68 (14) | 20–120 |
| Elastic modulus (MPa) | 0.14 (0.09) | 0.05–0.63 |
| PWVMK (m/s) | 3.53 (0.97) | 2.4–9.49 |
| CVD (n) | 21 | — |
| HT on treatment (n) | 62 | — |
| Diabetes (n) | 16 | — |
| Hyperlipidemia (n) | 9 | — |
Data are median (IQR)
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, PWVMK pulse wave velocity calculated using Moens–Kortweg equation, CVD cardiovascular disease, HT hypertension